Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$80.59 - $92.61 $8,864 - $10,187
-110 Reduced 0.22%
49,230 $4.21 Million
Q3 2023

Nov 09, 2023

BUY
$82.56 - $93.49 $1,651 - $1,869
20 Added 0.04%
49,340 $4.42 Million
Q2 2023

Aug 11, 2023

SELL
$80.84 - $89.45 $1.48 Million - $1.64 Million
-18,280 Reduced 27.04%
49,320 $4.2 Million
Q1 2023

May 10, 2023

BUY
$72.75 - $90.6 $632,925 - $788,220
8,700 Added 14.77%
67,600 $5.59 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $4.35 Million - $5.07 Million
58,900 New
58,900 $4.63 Million
Q3 2020

Nov 13, 2020

SELL
$75.65 - $93.58 $521,985 - $645,702
-6,900 Closed
0 $0
Q2 2020

Aug 11, 2020

SELL
$84.96 - $118.91 $2.62 Million - $3.67 Million
-30,860 Reduced 81.73%
6,900 $618,000
Q1 2020

May 12, 2020

SELL
$74.34 - $121.82 $59,472 - $97,456
-800 Reduced 2.07%
37,760 $3.76 Million
Q4 2019

Feb 12, 2020

BUY
$114.37 - $129.46 $480,354 - $543,732
4,200 Added 12.22%
38,560 $4.43 Million
Q3 2019

Nov 13, 2019

BUY
$117.16 - $138.52 $3.22 Million - $3.8 Million
27,460 Added 397.97%
34,360 $4.33 Million
Q2 2019

Aug 02, 2019

BUY
$81.74 - $120.34 $106,262 - $156,442
1,300 Added 23.21%
6,900 $830,000
Q1 2019

May 13, 2019

SELL
$83.25 - $102.12 $1.59 Million - $1.95 Million
-19,100 Reduced 77.33%
5,600 $490,000
Q4 2018

Feb 12, 2019

BUY
$90.66 - $116.63 $698,082 - $898,051
7,700 Added 45.29%
24,700 $2.47 Million
Q2 2018

Aug 13, 2018

SELL
$71.53 - $95.75 $71,530 - $95,750
-1,000 Reduced 5.56%
17,000 $1.53 Million
Q1 2018

May 14, 2018

SELL
$60.72 - $74.41 $303,600 - $372,050
-5,000 Reduced 21.74%
18,000 $1.32 Million
Q4 2017

Feb 13, 2018

BUY
$44.96 - $58.99 $1.03 Million - $1.36 Million
23,000
23,000 $1.34 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.23B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Hillsdale Investment Management Inc. Portfolio

Follow Hillsdale Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.